Composition for treatment of ocular hypertension and glaucoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/557 (2006.01) A61K 31/5575 (2006.01) A61P 27/06 (2006.01)

Patent

CA 2416681

15-keto prostaglandin compounds containing a ring structure at the end of the omega chain are used as ocular applied intraocular pressure reducing agents. They are applied in a dose below the known dose for the corresponding 15-OH compound.

La présente invention concerne des composés à base de 15-céto-prostaglandine, qui présentent une structure cyclique à l'extrémité de la chaîne oméga. Ces composés sont utilisés en tant qu'agents de réduction de la pression intra-oculaire, à application oculaire. Ils sont appliqués à une dose inférieure à la dose connue de composé à base de 15-OH correspondant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for treatment of ocular hypertension and glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for treatment of ocular hypertension and glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treatment of ocular hypertension and glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1891865

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.